The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intense exercise for survival among men with metastatic castrate-resistant prostate cancer (INTERVAL – MCRPC): A Movember funded multicenter, randomized, controlled phase III study.
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Novartis; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bavarian Nordic; Janssen Oncology; Millennium; Novartis; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Stacey A. Kenfield
No Relationships to Disclose
 
June M. Chan
Employment - Myriad Genetics (I)
Stock and Other Ownership Interests - Myriad Genetics (I)
Research Funding - GenomeDx (Inst); Genomic Health (Inst); Myriad Genetics (Inst)
Patents, Royalties, Other Intellectual Property - Patent for using nutrient gene interaction to predict aggressive prostate cancer
Travel, Accommodations, Expenses - Myriad Genetics (I)
 
Nicolas H. Hart
No Relationships to Disclose
 
Kerry S. Courneya
No Relationships to Disclose
 
James Catto
Consulting or Advisory Role - Abbott Laboratories
Research Funding - ArrayGenomics
Travel, Accommodations, Expenses - Abbott Diagnostics
 
Stephen P. Finn
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Pfizer
 
Rosemary Greenwood
No Relationships to Disclose
 
Daniel C Hughes
No Relationships to Disclose
 
Lorelei A. Mucci
No Relationships to Disclose
 
Stephen R Plymate
No Relationships to Disclose
 
Michael N. Pollak
No Relationships to Disclose
 
Stephan F.E. Praet
No Relationships to Disclose
 
Aaron P. Russell
No Relationships to Disclose
 
Emer M. Guinan
No Relationships to Disclose
 
Erin Van Blarigan
No Relationships to Disclose
 
Orla Casey
No Relationships to Disclose
 
Mark Buzza
No Relationships to Disclose
 
Charles J. Ryan
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Bayer; Millennium
Research Funding - BIND Biosciences; Karyopharm Therapeutics; Novartis
 
Robert Usher Newton
No Relationships to Disclose